Understanding how to improve protein management in retinal cells
Transcriptional Control of Proteostsis in Photoreceptors
This study is looking at how to help the light-sensitive cells in the eye survive longer in people with retinal diseases caused by genetic changes, by finding ways to improve how these cells handle proteins.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11045153 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind retinal degenerative diseases, which are caused by various genetic mutations. The focus is on enhancing the ability of photoreceptor cells to manage proteins effectively, particularly through the ubiquitin-proteasome system. By manipulating specific pathways that control protein degradation, the study aims to improve the survival of these crucial cells in the retina. The research employs genetic techniques in mouse models to explore the effects of stimulating certain regulatory pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic predispositions to retinal degenerative diseases or those experiencing early symptoms of vision loss.
Not a fit: Patients with retinal conditions unrelated to the ubiquitin-proteasome system or those with advanced stages of retinal degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance the survival of photoreceptor cells and potentially slow down or prevent vision loss in patients with retinal degenerative diseases.
How similar studies have performed: Previous research has shown promise in targeting the ubiquitin-proteasome system for therapeutic interventions in retinal diseases, indicating a potential for success with this approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Lobanova, Ekaterina — University of Pittsburgh at Pittsburgh
- Study coordinator: Lobanova, Ekaterina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.